Microbot Medical Inc. (NASDAQ:MBOT) shares are up on Tuesday following the announcement that Tampa General Hospital has become the first health system in Florida to adopt the company’s LIBERTY Endovascular Robotic System.

Microbot Medical’s recent achievement comes on the heels of its FDA 510(k) clearance for the LIBERTY system, which is designed for precision in peripheral endovascular procedures.

The adoption by Tampa General Hospital is seen as a significant endorsement of LIBERTY’s value, with the hospital’s leadership emphasizing the technology’s potential to transform patient care and enhance physician safety.

The LIBERTY system is the only FDA-cleared, single-use, remotely operated robotic solution in its category, aiming to address the growing demand in the U.S. market, which encompasses approximately 2.5 million procedures annually.

This strategic partnership is expected to enhance Microbot’s commercial footprint as it prepares for a full market release at the Society of Interventional Radiology conference in April 2026, allowing the company to showcase LIBERTY with the goal of deepening market adoption.

The company commenced the limited market release of the LIBERTY system in late 2025.

Technical Analysis

Over the past 12 months, shares have fluctuated within a range of $1.25 to $4.67, and are currently positioned closer to their 52-week lows than highs.

The RSI is at 50.00, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD is at -0.05, below its signal line at 0.00, indicating bearish pressure on the stock.

The combination of neutral RSI and bearish MACD suggests mixed momentum.

• Key Resistance: $3.00
• Key Support: $1.50

Recent analyst moves include:

• B. Riley Securities: Initiated with Buy (Target $5.00) (Feb. 10)
• Roth Capital: Initiated with Buy (Target $5.50) (Dec. 3, 2025)
• HC Wainwright & Co.: Buy (Maintains Target to $12.00) (Nov. 28, 2025)

MBOT Price Action: Microbot Medical shares were up 22.42% at $2.51 at the time of publication on Tuesday, according to Benzinga Pro data.

Photo: Shutterstock